S. Black brings biotech innovations to UK and Ireland

Published: 5-Apr-2007
Ingredients Pharmaceutical Nutraceutical

S. Black, of Hertford in the UK, has been appointed as the UK and Ireland distributor for biotech company Gnosis.


S. Black, of Hertford in the UK, has been appointed as the UK and Ireland distributor for biotech company Gnosis.

The Italian organisation has r&d laboratories in Desio, Milan; and a pharmaceutical GMP-approved manufacturing plant in San Antonino, Bellinzona, Switzerland - Gnosis BioResearch - where all operations including downstream processes have been carried out.

S. Black will be supporting Gnosis in the area of natural ingredients used primarily in the nutraceutical, pharmaceutical, veterinary and personal care markets.

See more

You may also like

Pharmaceutical

High-precision temperature control solutions for the pharmaceutical industry and biotechnology, available in the UK from Labtex

Read more
Huber offers a world-renowned range of temperature control systems and associated accessories for the Pharmaceutical Industry and Biotechnology

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the vaccine candidate drug substance commencing late in the third quarter of 2020
  2. Causes and solutions for dark spots in tablet manufacturing Natoli Engineering examines the causes and solutions for dark spots that can halt production
  3. Indian government bans three medicines owing to health risks Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
  4. Assessing the risks: the importance of a multifaceted approach to containment Risk assessment is a crucial component of any manufacturing process and plays a key role in terms of ensuring the well-being of workers and the quality of products, reports Gabriela Mikhaiel, Global Marketing and Communication Manager at Dec Group
  5. High-precision temperature control solutions for the pharmaceutical industry and biotechnology, available in the UK from Labtex Huber offers a world-renowned range of temperature control systems and associated accessories for the Pharmaceutical Industry and Biotechnology

Upcoming event

Lounges

23-25 April 2024 | Conference | Messe Karlsruhe, Germany See all

You may also like

Pharmaceutical

High-precision temperature control solutions for the pharmaceutical industry and biotechnology, available in the UK from Labtex

Huber offers a world-renowned range of temperature control systems and associated accessories for the Pharmaceutical Industry and Biotechnology
Manufacturing

CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery

The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
Sustainability

Building strong foundations for a resilient and planet-friendly future

Having recently released its inaugural environmental, social and governance (ESG) report, Dr Kevin Robinson caught up with Gigi Bat-Erdene, Global ESG Program Manager at PCI Pharma Services, to find out how this leading CDMO is tackling climate science, workforce empowerment, responsible waste management and supply chain security
Sustainability

Dickson achieves ISO 14001 certification

ISO 14001 certification highlights a companies' long-term efforts to manage its environmental impact
Regulatory

The key role of IVDs in healthcare: challenges to commercialisation and access

In simple terms, in vitro diagnostic (IVD) tests are done on samples such as blood or tissue that have been taken from the human body. IVDs can detect diseases, conditions and infections, provide patients with a better understanding of their ailment and how it might be managed and changed with treatment
Distribution

Tower Cold Chain launches live tracking and monitoring for pharmaceutical distribution

The upgrade allows customers to access real-time insights into shipments, facilitating the optimisation of cold chain processes
Manufacturing

Europe’s generic medicines are disappearing, study finds

Over a ten year period, the number of generic medicines withdrawn from the market increased by 12%
Subscribe now